HBI Deals+Insights / News
With France’s healthcare market facing sweeping reforms and tightening reimbursement rules, asset prices have dropped, presenting a rare opportunity for private equity investors and foreign healthcare providers to enter at a discount, provided they can navigate a shifting landscape marked by consolidation, tighter margins and rising regulatory scrutiny.





